Insider Title Company Date Price Return Shares Value
Sundaram Senthil Vel Chief Executive Officer Terns Pharmaceuticals, Inc. (TERN) 2023-05-31 $1.41 429.1% 2,111 $2,977
Sundaram Senthil Vel Chief Executive Officer Terns Pharmaceuticals, Inc. (TERN) 2022-11-30 $1.41 429.1% 3 $4
Sundaram Senthil Vel Chief Executive Officer Terns Pharmaceuticals, Inc. (TERN) 2022-05-31 $1.47 407.5% 7,656 $11,254
Return Profit / (loss) Cost
Total 412.0% $58,649 $14,235